Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00454389
What this trial is testing

Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
NeoVista 494
Not applicableStudy completedNCT00383825
What this trial is testing

ICG Angiography in Amniotic Membrane Graft and Conjunctival Autograft After Pterygium Excision

Who this might be right for
Pterygium
Baskent University 30
Not applicableStudy completedNCT05662943
What this trial is testing

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Who this might be right for
Polypoidal Choroidal VasculopathyChoroidal NeovascularizationAge-Related Macular Degeneration
Kim's Eye Hospital 135
Testing effectiveness (Phase 2)Study completedNCT02603406
What this trial is testing

Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits

Who this might be right for
AngiogenesisIschemic Stroke
Ajou University School of Medicine 44
Not applicableStudy completedNCT03884049
What this trial is testing

Neovascularization Embolisation for Knee Osteoarthritis.(NEO)

Who this might be right for
Osteoarthritis, Knee
Erasmus Medical Center 58
Testing effectiveness (Phase 2)Study completedNCT01769183
What this trial is testing

Squalamine for the Treatment in Proliferative Diabetic Retinopathy

Who this might be right for
Retinal Neovascularization
Elman Retina Group 6
Testing effectiveness (Phase 2)Ended earlyNCT01021956
What this trial is testing

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Steba Biotech S.A. 10
Testing effectiveness (Phase 2)Study completedNCT00612456
What this trial is testing

To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD

Who this might be right for
Macular Degeneration
GlaxoSmithKline 70
Testing effectiveness (Phase 2)Study completedNCT00753025
What this trial is testing

Autologous Bone Marrow For Lower Extremity Ischemia Treating

Who this might be right for
Lower Extremity Ischemia
Clinical Center of Cellular Technologies, Russia 42
Not applicableStudy completedNCT02175940
What this trial is testing

VEGF and PEDF in Patients With Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularizationVEGF Aqueous LevelPEDF Aqueous Level
Università degli Studi di Brescia 40
Not applicableUnknownNCT04686110
What this trial is testing

Analysis of Capillary Retinal and Papillary Vascularization in Patients With Amyotrophic Lateral Sclerosis - CAPISLA

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Angers 94
Large-scale testing (Phase 3)Study completedNCT03844074
What this trial is testing

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration
Outlook Therapeutics, Inc. 61
Testing effectiveness (Phase 2)Ended earlyNCT00712491
What this trial is testing

Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Santen Inc. 20
Large-scale testing (Phase 3)UnknownNCT00517257
What this trial is testing

Atorvastatin for the Treatment of Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionRetinal Vein ThrombosisCentral Retinal Vein Occlusion+2 more
University of Toronto 180
Early research (Phase 1)Ended earlyNCT00005655
What this trial is testing

Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

Who this might be right for
Kidney NeoplasmLung NeoplasmSarcoma+1 more
National Cancer Institute (NCI) 39
Large-scale testing (Phase 3)Study completedNCT00021736
What this trial is testing

Phase II/III Study of Anti-VEGF in Neovascular AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Eyetech Pharmaceuticals 540
Post-approval studies (Phase 4)Study completedNCT01831947
What this trial is testing

Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.

Who this might be right for
Macular Degeneration
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40
Early research (Phase 1)Study completedNCT00295828
What this trial is testing

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

Who this might be right for
Iris NeovascularizationDiabetic Retinopathy
Hermann Eye Center 10
Testing effectiveness (Phase 2)Study completedNCT01445899
What this trial is testing

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Who this might be right for
Choroidal NeovascularizationDiabetic RetinopathyDiabetic Macular Edema
Quark Pharmaceuticals 258
Large-scale testing (Phase 3)Study completedNCT00826371
What this trial is testing

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

Who this might be right for
Age Related Macular Degeneration
Novartis Pharmaceuticals 114
Next Page